image description

איתן שכטמן 2013-2014

מוסד לימודים לדוקטורט:
האוניברסיטה העברית בירושלים
תחום אקדמי:
חישוביות עצבית
מנחה/מנחים בדוקטורט:
פרופ' חגי ברגמן
נושא הדוקטורט:
The Cellular Physiology and Cognitive Function of the External Segment of the Globus Pallidus
מוסד בתר-דוקטורט:
אוניברסיטת נורת'ווסטרן
מוסד נוכחי:
אוניברסיטת נורת'ווסטרן
משרה אקדמית נוכחית:
בתר-דוקטורנט
כתובת דוא"ל:
eitan.schechtman@mail.huji.ac.il
קורות חיים
Links to Recent Publications:
Publication 1
Links to Relevant Media (written & videos):
Media 1
עמוד הבית

Eitan, born in 1981, was raised in Rehovot and currently resides in Ora, near Jerusalem. Following his military service, he realized his passion for research and knowledge. Three years later, he completed his BA in Psychology summa cum laude, had published a paper in a high impact journal – and two others were underway. He was fascinated with the interaction between neural activity, cognition and behavior.  Eitan joined the direct PhD program at the ICNC. He is currently conducting his doctoral studies at the Edmund and Lily Safra Center for Brain Sciences under Prof. Hagai Bergman at the Hebrew University’s Faculty of Medicine.

Eitan’s primary focus in his study is schizophrenia, a devastating disorder affecting approximately one percent of the population. Eitan’s study focuses on the electrophysiological properties of single neurons in the Basal Ganglia, a brain region which is involved in emotional and goal related processing and planning. This region has long been implicated in schizophrenia, but its direct involvement remains an unresolved issue. Using methods to record and analyze the activity of the smallest computational unit in the brain, the neuron, Eitan expects to uncover key aspects of the brain insult that results in schizophrenia.

Eitan’s dream is to use his results to advance the treatment of schizophrenia. Specifically, Eitan wishes to consider the effects of Deep Brain Stimulation (DBS), a highly successful treatment used mostly for Parkinson’s disease, on the symptoms of schizophrenia. DBS has previously proven efficient for psychiatric conditions such as major depression but has not been thoroughly considered for the treatment of schizophrenia. Eitan’s results are expected to pave the way for the evaluation of such treatment in human patients.

In addition to his research, Eitan is highly committed to his volunteer work in two nonprofit organizations, aiming to improve the social acceptance of the LGBT (lesbian, gay, bisexual and transgender) community.  He lives in Ora, near Jerusalem, with his husband and daugther.

Eitan will begin his postdoctoral research in Northwestern University during October 2016.